With over three decades of R&D leadership, Dr. Pejaver brings unparalleled expertise in the development and regulatory approval of injectables, ophthalmics, and semi-solid drug products.
- Spearheaded 100+ ANDAs and numerous 505(b)(2) submissions
- Filed 40+ patents globally, with 20+ granted
- Expert in regulatory strategy and first-to-market positioning
- Driving science-led innovation with a sharp strategic edge in complex generics
and advanced delivery systems.
- Proven success in guiding companies to profitability or strategic exits
